Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: Update of a single-center prospective phase II protocol

Strahlentherapie und Onkologie

Volumn 186, Issue 5, 2010, Pages 255-261

  Berger, Bernhard ^a   Belka, Claus ^b   Weinmann, Martin ^a   Bamberg, Michael ^a   Budach, Wilfried ^c   Hehr, Thomas ^d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d MARIENHOSPITAL STUTTGART   (Germany)

Author keywords

Chemoradiation; Docetaxel; Radiochemotherapy; Recurrent head and neck cancer; Reirradiation

Indexed keywords

CISPLATIN; DOCETAXEL; RADIOSENSITIZING AGENT; TAXOID;

ARTICLE; BLOOD TOXICITY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DRUG DOSE REDUCTION; DYSPHAGIA; FIBROSIS; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LYMPHEDEMA; METASTASIS; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; RADIATION DOSE; RETREATMENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; ADOLESCENT; ADULT; AGED; FEMALE; HEAD AND NECK TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY; SQUAMOUS CELL CARCINOMA; SURVIVAL; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TAXOIDS;

EID: 77952775009     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2082-9     Document Type: Article

References (27)

1. F. Ayukawa H. Shibuya R. Yoshimura, et al. 2007 Curative brachytherapy for recurrent/ residual tongue cancer Strahlenther Onkol 183 133 137 10.1007/s00066-007-1613-5 17340071 (Pubitemid 46364897)
2. J. Bernier C. Vrieling 2008 Docetaxel in the management of patients with head and neck squamous cell carcinoma Expert Rev Anticancer Ther 8 1023 1032 10.1586/14737140.8.7.1023 1:CAS:528:DC%2BD1cXnslyrtLo%3D 18588449
3. M.C. Biagioli M. Harvey E. Roman, et al. 2007 Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer Int J Radiat Oncol Biol Phys 69 1067 1073 17967302
4. R. De Crevoisier J. Bourhis C. Domenge, et al. 1998 Full-dose reirradiation for unresectable head and neck carcinoma: experience at the Gustave-Roussy Institute in a series of 169 patients J Clin Oncol 16 3556 3562 9817275
5. R.I. Haddad D.M. Shin 2008 Recent advances in head and neck cancer N Engl J Med 359 1143 1154 10.1056/NEJMra0707975 1:CAS:528:DC%2BD1cXhtFWrsLvI 18784104
6. T. Hehr J. Classen C. Belka, et al. 2005 Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I/II trial Int J Radiat Oncol Biol Phys 61 1423 1431 1:CAS:528:DC%2BD2MXjtV2ju7s%3D 15817346
7. B.A. Jereczek-Fossa A. Kowalczyk A. D'Onofrio, et al. 2008 Three-dimensional conformal or stereotactic reirradiation of recurrent, metastatic or new primary tumors. Analysis of 108 patients Strahlenther Onkol 184 36 40 10.1007/s00066-008-1783-9 18188521
8. N. Kasperts B. Slotman C.R. Leemans J.A. Langendijk 2005 A review on re-irradiation for recurrent and second primary head and neck cancer Oral Oncol 41 225 243 10.1016/j.oraloncology.2004.07.006 1:STN:280:DC%2BD2M7htlOltw%3D%3D 15743686 (Pubitemid 40326169)
9. 192Ir HDR brachytherapy Strahlenther Onkol 183 69 75 10.1007/s00066-007-1632-2 17294110
10. J.A. Langendijk J. Bourhis 2007 Reirradiation in squamous cell head and neck cancer: recent developments and future directions Curr Opin Oncol 19 202 209 10.1097/CCO.0b013e3280f00ff8 17414637 (Pubitemid 46597478)
11. C.J. Langer J. Harris E.M. Horwitz, et al. 2007 Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911 J Clin Oncol 25 4800 4805 10.1200/JCO.2006.07.9194 1:CAS:528:DC%2BD2sXhtlCgsLbK 17947728 (Pubitemid 350086484)
12. N. Lee K. Chan J.E. Bekelman, et al. 2007 Salvage re-irradiation for recurrent head and neck cancer Int J Radiat Oncol Biol Phys 68 731 740 17379449
13. W.B. Looney H.A. Hopkins 1991 Rationale for different chemotherapeutic and radiation therapy strategies in cancer management Cancer 67 1471 1483 10.1002/1097-0142(19910315)67:6<1471::AID-CNCR2820670602>3.0.CO;2-G 1:STN:280:DyaK3M7lvF2isA%3D%3D 2001534
14. M. Merlano M. Benasso R. Corvò, et al. 1996 Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck J Natl Cancer Inst 88 583 589 10.1093/jnci/88.9.583 1:STN:280:DyaK287pvFykuw%3D%3D 8609658 (Pubitemid 26139938)
15. M.T. Milano E.E. Vokes J.K. Salama, et al. 2005 Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy Int J Radiat Oncol Biol Phys 61 1096 1106 1:CAS:528:DC%2BD2MXhvFykt7Y%3D 15752889
16. D. Rades M. Stoehr T. Meyners, et al. 2008 Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer Strahlenther Onkol 184 198 205 10.1007/s00066-008-1825-3 18398584 (Pubitemid 351508132)
17. J.K. Salama D.J. Haraf K. Stenson, et al. 2005 Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer Cancer J 11 140 146 10.1097/00130404-200503000-00009 1:CAS:528:DC%2BD2MXls1aqu78%3D 15969989
18. J.K. Salama E.E. Vokes S.J. Chmura, et al. 2006 Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 64 382 391 16213104
19. T.Y. Seiwert J.K. Salama E.E. Vokes 2007 The chemoradiation paradigm in head and neck cancer Nat Clin Pract Oncol 4 156 171 10.1038/ncponc0750 1:CAS:528:DC%2BD2sXjvV2rurY%3D 17327856 (Pubitemid 46358853)
20. S.A. Spencer J. Harris R.H. Wheeler, et al. 2001 RTOG 9610: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck Int J Radiat Oncol Biol Phys 51 1299 1304 1:CAS:528:DC%2BD3MXos1Kmtrk%3D 11728690
21. F. Sterzing K. Schubert G. Sroka-Perez, et al. 2008 Helical tomotherapy. Experiences of the first 150 patients in Heidelberg Strahlenther Onkol 184 8 14 10.1007/s00066-008-1778-6 18188517
22. E.P. Sulman D.L. Schwartz T.T. Le, et al. 2009 IMRT reirradiation of head and neck cancer - disease control and morbidity outcomes Int J Radiat Oncol Biol Phys 73 399 409 18556144
23. P. Therasse S.G. Arbuck E.A. Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 10.1093/jnci/92.3.205 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10655437
24. J.B. Vermorken R. Mesia F. Rivera, et al. 2008 Platinum-based chemotherapy plus cetuximab in head and neck cancer N Engl J Med 359 1116 1127 10.1056/NEJMoa0802656 1:CAS:528:DC%2BD1cXhtFWrsrnI 18784101
25. E.E. Vokes W.R. Panje R.L. Schilsky, et al. 1989 Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study J Clin Oncol 7 761 768 1:STN:280:DyaL1M3jsFKqug%3D%3D 2715806
26. M. Voordeckers H. Everaert K. Tournel, et al. 2008 Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer Strahlenther Onkol 184 400 405 10.1007/s00066-008-1836-0 18956516
27. S.J. Wong M. Machtay Y. Li 2006 Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 24 2653 2658 10.1200/JCO.2005.05.3850 16763279 (Pubitemid 46622086)